Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-γ

International Journal of Cancer

Volumn 82, Issue 5, 1999, Pages 727-736

  Ugurel, Selma ^a   Seiter, Simone ^a   Rappl, Gunter ^a   Stark, Alexandra ^a   Tilgen, Wolfgang ^a   Reinhold, Uwe ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; FAS ANTIGEN; GAMMA INTERFERON; MONOCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN BCL X; BCL2L1 PROTEIN, HUMAN; CARRIER PROTEIN; CFLAR PROTEIN, HUMAN; FLICE INHIBITORY PROTEIN; SIGNAL PEPTIDE;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; CELL CULTURE; CELL DEATH; CYTOTOXICITY; MELANOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANTIGENS, CD95; APOPTOSIS; BCL-X PROTEIN; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL DEATH; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERFERON TYPE II; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0033609672     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990827)82:5<727::AID-IJC17>3.0.CO;2-E     Document Type: Article

References (25)

1. AGARWALA, S.S. and KIRKWOOD, J.M., Interferons in melanoma. Curr. Opin. Oncol, 8, 167-174 (1996).
2. BOISE, L.H., GONZALEZ-GARCIA, M., POSTEMA, C.E., DING, L., LINDSTEN, T., TURKA, L.A., MAO, X., NUNEZ, G. and THOMPSON, C.B., bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608 (1993).
3. BUECHNER, S.A., WERNLI, M., HARR, T., HAHN, S., ITIN, P. and ERB, P., Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide. J. din. Invest, 100, 2691-2696 (1997).
4. GROVER, R. and WILSON, G.D., bcl-2 expression in malignant melanoma and its prognostic significance. Europ. J. surg. Oncol., 22, 347-349 (1996).
5. HAHNE, M., RIMOLDI, D., SCHROETER, M., ROMERO, P., SCHREIER, M., FRENCH, L.E., SCHNEIDER, P., BORNAND, T., FONTANA, A., LIENARD, D., CEROTTINI, J. and TSCHOPP, J., Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science, 274, 1363-1366 (1996).
6. HOCKENBERY, D.M., bcl-2 in cancer, development and apoptosis. J. Cell Sci., Suppl, 18, 51-55 (1994).
7. IRMLER, M. and 12 OTHERS, Inhibition of death receptor signals by cellular FLIP. Nature (Lond.), 388, 190-195 (1997).
8. KEANE, M.M., ETTENBERG, S.A., LOWREY, O.A., RUSSELL, E.K. and LIPKOWITZ, S., Fas expression and function in normal and malignant breast cell lines. Cancer Res., 56, 4791-4798 (1996).
9. LEITHAEUSER, F., DHEIN, J., MECHTERSHEIMER, G., KORETZ, K., BRUEDERLEIN, S., HENNE, C., SCHMIDT, A., DEBATIN, K.M., KRAMMER, P.H. and MOELLER. P., Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest., 69, 415-429 (1993).
10. LUCKING-FAMIRA, K.M., DANIEL, P.T., MOELLER, P., KRAMMER, P.H. and DEBATIN, K.M., APO-1 (CD95) mediated apoptosis in human T-ALL engrafted in SCID mice. Leukemia, 8, 1825-1833 (1994).
11. MORALES-DUCRET, C.R., VAN DE RUN, M., LEBRUN, D.P. and SMOLLER, B.R., bcl-2 expression in primary malignancies of the skin. Arch. Dermatol., 131, 909-912 (1995).
12. MORIMOTO, H., YONEHARA, S. and BONAVIDA, B., Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res., 53, 2591-2596 (1993).
13. NAGATA, S. and GOLSTEIN, P., The Fas death factor. Science, 267, 1449-1456 (1995).
14. NONOMURA, N., MIKI, T., YOKOYAMA, M., IMAZU, T., TAKADA, T., TAKEUCHI, S., KANNO, N., NISHIMURA, K., KOJIMA, Y. and OKUYAMA, A., Fas/APO-1-mediated apoptosis of human renal cell carcinoma. Biochem. biophys. Res. Comm., 229, 945-951 (1996).
15. OWEN-SCHAUB, L.B., RADINSKY, R., KRUZEL, E., BERRY, K. and YONEHARA, S., Anti-Fas on non-hematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res., 54, 1580-1586 (1994).
16. PLETTENBERG, A., BALLAUN, C., PAMMER, J., MILDNER, M., STRUNK, D., WENINGER, W. and TSCHACHLER, E., Human melanocytes and melanoma cells constitutively express the bcl-2 proto-oncogene in situ and in cell culture. Amer. J. Pathol., 146, 651-659 (1995).
17. + CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for rumor killing. J. Immunol., 161, 1220-1230 (1998).
18. RODRIGUEZ-VILLANUEVA, J. and MCDONNELL, T.J., Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha. Int. J. Cancer, 61,110-114(1995).
19. SELLERI, C., SATO, T., DEL VECCHIO, L., LUCIANO, L., BARRETT, A.J., ROTOLI, B., YOUNG, N.S. and MACIEJEWSKI, J.P., Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia. Blood, 89, 957-964 (1997).
20. SELZER, E., SCHLAOBAUER-WADL, H., OKAMOTO, I., PEHAMBERGER, H., POTTER, R. and JANSEN, B., Expression of bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines. Melanoma Res., 8, 197-203 (1998).
21. THILENIUS, A.R., BRAUN, K. and RUSSELL, J.H., Agonist antibody and Fas ligand mediate different sensitivity to death in the signaling pathways of Fas and cytoplasmic mutants. Europ. J. Immunol., 27, 1108-1114 (1997).
22. THOMAS, W.D. and HERSEY, P., CD4 T cells kill melanoma cells by mechanisms that are independent of Fas (CD95). Int. J. Cancer, 75, 384-390 (1998).
23. TRAUTH, B.C., KLAS, C., PETERS, A.M., MATZKU, S., MOELLER, P., FALK, W., DEBATIN, K.M. and KRAMMER, P.H., Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science, 245, 301-305 (1989).
24. WELLER, M., FREI, K., GROSCURTH, P., KRAMMER, P.H., YONEKAWA, Y. and FONTANA, A., Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J. clin. Invest., 94, 954-964 (1994).
25. ZIPP, F., MARTIN, R., LICHTENFELS, R., ROTH, W., DICHGANS, J., KRAMMER, P.H. and WELLER, M., Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand. J. Immunol., 159, 2108-2115 (1997).